Want to see XNDU full AI Analyst Report?
Top Page
Xanadu Quantum Technologies
(NASDAQ:XNDU)
Select Model
Select Model
Rating:52Neutral
Price Target:
$13.50
▼(-55.30% Downside)
Action:Reiterated
Date:06/10/26
Overall score is held back primarily by operational weakness (revenue collapsing to $0 and ongoing negative operating/free cash flow) despite a significantly strengthened, debt-free balance sheet. Technical indicators also point to a continuing downtrend, while valuation is difficult to assess due to a negative P/E and no dividend data.
Positive Factors
Balance sheet strength
A debt-free capital structure and a materially larger equity base provide a durable financial cushion that lowers solvency risk, supports continued R&D and capital spending, and reduces near-term refinancing pressure, improving runway and strategic optionality.
Negative Factors
Revenue collapse
A complete drop to zero reported revenue undermines product-market validation and recurring income. Without a sustainable sales base, profitability gains may rely on one-offs or accounting items, raising risk that earnings improvements are not durable as commercialization remains unproven.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance sheet strength
A debt-free capital structure and a materially larger equity base provide a durable financial cushion that lowers solvency risk, supports continued R&D and capital spending, and reduces near-term refinancing pressure, improving runway and strategic optionality.
Read all positive factors
Xanadu Quantum Technologies (XNDU) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$3.31B
Dividend YieldN/A
Average Volume (3M)87.66K
Price to Earnings (P/E)―
Beta (1Y)5.69
Revenue GrowthN/A
EPS GrowthN/A
CountryUS
Employees3
SectorGeneral
Sector StrengthN/A
IndustrySoftware - Infrastructure
Share Statistics
EPS (TTM)-0.61
Shares Outstanding43,284,412
10 Day Avg. Volume209,945
30 Day Avg. Volume87,656
Financial Highlights & Ratios
PEG Ratio-0.36
Price to Book (P/B)1.19
Price to Sales (P/S)76.25
P/FCF Ratio-129.08
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$44.00Price Target Upside45.70% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-0.47
Revenue Forecast (FY)$5.51M
Xanadu Quantum Technologies Business Overview & Revenue Model
Company Description
Xanadu Quantum Technologies Inc. specializes in the creation and delivery of photonic quantum computing solutions, encompassing both sophisticated hardware and versatile software platforms. Their hardware offerings include cloud-accessible "x-seri...
How the Company Makes Money
null...
Xanadu Quantum Technologies Financial Statement Overview
Summary
Income Statement
28
Negative
Balance Sheet
82
Very Positive
Cash Flow
24
Negative
| Breakdown | Mar 2026 | Dec 2024 | Dec 2023 |
|---|---|---|---|
Income Statement | |||
| Total Revenue | 4.62M | 1.59M | 2.48M |
| Gross Profit | 4.26M | 1.12M | 1.87M |
| EBITDA | -63.93M | -40.28M | -31.07M |
| Net Income | -70.67M | -45.97M | -35.59M |
Balance Sheet | |||
| Total Assets | 310.84M | 116.77M | 150.98M |
| Cash, Cash Equivalents and Short-Term Investments | 367.35K | 77.62M | 117.46M |
| Total Debt | 0.00 | 24.88M | 16.99M |
| Total Liabilities | 14.15M | 29.27M | 19.08M |
| Stockholders Equity | 296.69M | 87.50M | 131.90M |
Cash Flow | |||
| Free Cash Flow | -2.73M | -48.41M | -39.97M |
| Operating Cash Flow | -2.73M | -41.74M | -29.55M |
| Investing Cash Flow | -301.87M | -6.67M | -9.97M |
| Financing Cash Flow | 304.96M | 9.29M | 4.31M |
Xanadu Quantum Technologies Risk Analysis
Xanadu Quantum Technologies disclosed 99 risk factors in its most recent earnings report. Xanadu Quantum Technologies reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Xanadu Quantum Technologies Peers Comparison
UnderperformOutperform
Sector (55)
XNDU
Xanadu Quantum Technologies
10.86
0.86
8.60%
ARQQ
Arqit Quantum
18.25
-25.06
-57.86%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.